Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Moodys
McKesson
McKinsey
Dow

Last Updated: January 27, 2023

CLINICAL TRIALS PROFILE FOR ORPHENADRINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Orphenadrine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01263652 ↗ Patient Preferences, Analgesic Delivery Method and Pain Reduction in Spine Patients Withdrawn Western Galilee Hospital-Nahariya N/A 2010-12-31 The investigators will conduct a randomized double blind study, to determine whether patient analgesic delivery mode preference affects pain reduction quality in non-surgical spine patients. The patients will receive both intra-muscular and oral non-narcotic analgesics and placebo. During the study period, pain reduction parameters will be collected. At the end of the study period, the investigators will attempt to find a correlation between pre-study patient preferences and the quality of the pain reduction achieved.
NCT02423395 ↗ Study of Orphenadrine' in the Treatment of Muscle Cramps in Patients With Cirrhosis Recruiting Tanta University Phase 3 2015-01-01 Muscle cramps are common in patients with liver disease and associated with significantly diminished quality of life. Patients with cirrhosis often experience muscle cramps with varied frequency and severity. The exact mechanisms by which they occur remain unclear, although a number of pathophysiological events unique to liver disease may contribute. Clinical studies have identified alterations in 3 areas: nerve function, energy metabolism, and plasma volume/electrolytes (1) Orphenadrine is an anticholinergic drug with prominent central nervous system (CNS) and peripheral actions used to treat painful muscle spasms and other similar conditions. The combination of anticholinergic effects and CNS penetration make orphenadrine useful for pain of all etiologies, including from: radiculopathy, muscles, and headaches. [3,4]
NCT02423395 ↗ Study of Orphenadrine' in the Treatment of Muscle Cramps in Patients With Cirrhosis Recruiting Sherief Abd-Elsalam Phase 3 2015-01-01 Muscle cramps are common in patients with liver disease and associated with significantly diminished quality of life. Patients with cirrhosis often experience muscle cramps with varied frequency and severity. The exact mechanisms by which they occur remain unclear, although a number of pathophysiological events unique to liver disease may contribute. Clinical studies have identified alterations in 3 areas: nerve function, energy metabolism, and plasma volume/electrolytes (1) Orphenadrine is an anticholinergic drug with prominent central nervous system (CNS) and peripheral actions used to treat painful muscle spasms and other similar conditions. The combination of anticholinergic effects and CNS penetration make orphenadrine useful for pain of all etiologies, including from: radiculopathy, muscles, and headaches. [3,4]
NCT02449369 ↗ Intra-Venous Acetaminophen and Muscle Relaxants After Total Knee Completed Sagent Pharmaceuticals Inc. Phase 4 2015-04-01 This is a prospective, three-arm, randomized, open-label trial to determine if a new pain control protocol which includes regular dosing of intravenous acetaminophen and orphenadrine for 48 hours after total knee surgery reduces the need for opioid pain medication and reduces average pain scores.
NCT02449369 ↗ Intra-Venous Acetaminophen and Muscle Relaxants After Total Knee Completed Sagent Pharmaceuticals, Inc. Phase 4 2015-04-01 This is a prospective, three-arm, randomized, open-label trial to determine if a new pain control protocol which includes regular dosing of intravenous acetaminophen and orphenadrine for 48 hours after total knee surgery reduces the need for opioid pain medication and reduces average pain scores.
NCT02449369 ↗ Intra-Venous Acetaminophen and Muscle Relaxants After Total Knee Completed AdventHealth Phase 4 2015-04-01 This is a prospective, three-arm, randomized, open-label trial to determine if a new pain control protocol which includes regular dosing of intravenous acetaminophen and orphenadrine for 48 hours after total knee surgery reduces the need for opioid pain medication and reduces average pain scores.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Orphenadrine Hydrochloride

Condition Name

Condition Name for Orphenadrine Hydrochloride
Intervention Trials
Pain, Postoperative 2
Constipation Drug Induced 1
Pain Management 1
Cruciate Ligament Rupture 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Orphenadrine Hydrochloride
Intervention Trials
Muscle Cramp 2
Low Back Pain 2
Back Pain 2
Pain, Postoperative 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Orphenadrine Hydrochloride

Trials by Country

Trials by Country for Orphenadrine Hydrochloride
Location Trials
Egypt 3
United States 3
Russian Federation 1
Israel 1
Austria 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Orphenadrine Hydrochloride
Location Trials
Illinois 1
New York 1
Florida 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Orphenadrine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Orphenadrine Hydrochloride
Clinical Trial Phase Trials
Phase 4 5
Phase 3 2
N/A 4
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Orphenadrine Hydrochloride
Clinical Trial Phase Trials
Completed 4
Unknown status 3
Recruiting 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Orphenadrine Hydrochloride

Sponsor Name

Sponsor Name for Orphenadrine Hydrochloride
Sponsor Trials
Montefiore Medical Center 2
Petrovsky National Research Centre of Surgery 1
Albert Einstein College of Medicine 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Orphenadrine Hydrochloride
Sponsor Trials
Other 16
Industry 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Moodys
Mallinckrodt
Baxter
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.